GoldAID Eicosapentaenoic Acid
Showing 1 - 25 of 8,206
Patients With Gestational Diabetes
Not yet recruiting
- Gestational Diabetes
- eicosapentaenoic acid
- (no location specified)
Oct 19, 2022
Bipolar Disorder Trial in New York (Ethyl Eicosapentaenoic Acid)
Withdrawn
- Bipolar Disorder
- Ethyl Eicosapentaenoic Acid
-
New York, New YorkNew York State Psychiatric Institute/Columbia University Medical
Oct 12, 2022
Type 2 Diabetes, Coronary Artery Disease Trial in Boston (Icosapent ethyl)
Terminated
- Type 2 Diabetes
- Coronary Artery Disease
- Icosapent ethyl
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 22, 2022
Dry Eye Syndromes, Age-Related Macular Degeneration, Omega 3 Index Trial in Pomona (OmegaBoost, Nature Made (soft gel), Nature
Active, not recruiting
- Dry Eye Syndromes
- +2 more
- OmegaBoost
- +2 more
-
Pomona, CaliforniaWestern University of Health Sciences
Mar 8, 2023
Diabetes Type 2, Hypertriglyceridemia, Diabetes Trial in Ioannina (EPAVasc, Corn Oil)
Not yet recruiting
- Diabetes Type 2
- +2 more
- EPAVasc
- Corn Oil
-
Ioannina, Epirus, GreeceAtherothrombosis Research Centre / Laboratory of Biochemistry, U
Nov 13, 2023
MDD, Overweight, Inflammation Trial in Atlanta, Boston (Placebo, EPA 1 g/day, EPA 2 g/day)
Completed
- Major Depressive Disorder
- +2 more
- Placebo
- +3 more
-
Atlanta, Georgia
- +1 more
Apr 4, 2022
Concussion, Mild Trial in Winnipeg (Omega-3, Placebo)
Not yet recruiting
- Concussion, Mild
- Omega-3
- Placebo
-
Winnipeg, Manitoba, CanadaApplied Research Centre, Faculty of Kinesiology, University of M
Apr 27, 2023
Breast Cancer Trial in Duarte, Columbus (omega 3 fatty acids)
Active, not recruiting
- Breast Cancer
- omega 3 fatty acids
-
Duarte, California
- +1 more
Jun 8, 2022
Healthy Diet Trial in Columbus (Algae Oil Fortified Soymilk, Algae Oil Capsule)
Recruiting
- Healthy Diet
- Algae Oil Fortified Soymilk
- Algae Oil Capsule
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 4, 2023
Cholesterol, Triglycerides, Omega-3 Trial in Tempe, Houston (AlmegaPL)
Not yet recruiting
- Cholesterol
- +3 more
- AlmegaPL
-
Tempe, Arizona
- +1 more
Feb 23, 2022
Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver
Recruiting
- Colon Cancer Liver Metastasis
- Icosapent Ethyl Oral Capsule
- Placebo
-
Leeds, United Kingdom
- +1 more
Sep 27, 2021
Colorectal Adenoma, Colorectal Cancer, Endoscopic Surgery Trial in Boston (AMR101)
Completed
- Colorectal Adenoma
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital
Nov 18, 2022
Familial Adenomatous Polyposis Trial in Bologna (Eicosapentaenoic acid free fatty acid (EPA-FFA), Placebo)
Recruiting
- Familial Adenomatous Polyposis
- Eicosapentaenoic acid free fatty acid (EPA-FFA)
- Placebo
-
Bologna, ItalyUniversity of Bologna and St.Orsola-Malpighi Hospital
Oct 26, 2022
Chronic Venous Leg Ulcers Trial in Columbus (EPA+DHA, )
Recruiting
- Chronic Venous Leg Ulcers
- EPA+DHA
- placebo
-
Columbus, OhioThe Ohio State University College of Nursing
Mar 29, 2022
Metabolic Syndrome Trial in Boston (EPA, DHA, sunflower oil)
Completed
- Metabolic Syndrome
- EPA
- +2 more
-
Boston, MassachusettsJean Mayer Human Nutrition Research Center on Aging at Tufts Uni
Apr 13, 2021
Fatty Liver, Bariatric Surgery Candidate Trial in Singapore (2 capsules of Concentrated omega-3 triglycerides- fish 1000mg
Recruiting
- Fatty Liver
- Bariatric Surgery Candidate
- 2 capsules of Concentrated omega-3 triglycerides- fish 1000mg (600mg Eicosapentaenoic acid (EPA), 1400mg Docosahexaenoic acid (DHA)) per day
-
Singapore, SingaporeKhoo Teck Puat Hospital
Sep 12, 2021
Alzheimer's Disease Trial in Madison (icosapent ethyl (IPE), gel cap )
Active, not recruiting
- Alzheimer's Disease
- icosapent ethyl (IPE)
- gel cap placebo
-
Madison, WisconsinWilliam S. Middleton Memorial Veterans Hospital, Madison, WI
Jul 23, 2021
Inflammation Trial in Maria, Rimouski (Eicosapentaenoic acid monoglycerid (MAG-EPA))
Recruiting
- Inflammation
- Eicosapentaenoic acid monoglycerid (MAG-EPA)
-
Maria, Quebec, Canada
- +1 more
May 31, 2021
SARS-CoV-2 Trial in Spain, United Kingdom (Eicosapentaenoic acid gastro-resistant capsules, Placebo)
Recruiting
- SARS-CoV-2
- Eicosapentaenoic acid gastro-resistant capsules
- Placebo
-
Barcelona, Spain
- +4 more
Nov 26, 2021
Lipoprotein Metabolism, PCSK9, Proteomics Trial run by the NHLBI (EPA-rich fish oil, DHA-rich fish oil)
Completed
- Lipoprotein Metabolism
- +2 more
- EPA-rich fish oil
- DHA-rich fish oil
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 25, 2021
Weight Gain, Healthy Subjects, Obesity Trial run by the NIAAA (Linoleic Acid, Docosahexaenoic Acid, Eicosapentaenoic Acid)
Completed
- Weight Gain
- +3 more
- Linoleic Acid
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 6, 2021
Barrett's Esophagus, Obesity Trial in Rochester (Omega-3 polyunsaturated fatty acids, Placebo)
Completed
- Barrett's Esophagus
- Obesity
- Omega-3 polyunsaturated fatty acids
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 13, 2021
Brain Health, Brain Function, Brain Development Trial in Winston-Salem (Fish Oil, Safflower Oil)
Terminated
- Brain Health
- +2 more
- Fish Oil
- Safflower Oil
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Jun 2, 2021
Liver Metastasis, Colon Cancer Trial in United Kingdom (Icosapent Ethyl, Placebo)
Recruiting
- Liver Metastasis
- Colon Cancer
- Icosapent Ethyl
- Placebo
-
Oxford, Oxfordshire, United Kingdom
- +12 more
Nov 7, 2022
Traumatic Brain Injury (TBI), Chronic Traumatic Encephalopathy (CTE) Trial in Tucson (Fish Oil (DPA+EPA 2:1 ratio) Capsules,
Completed
- Traumatic Brain Injury (TBI)
- Chronic Traumatic Encephalopathy (CTE)
- Fish Oil (DPA+EPA 2:1 ratio) Capsules
- High Oleic Safflower Oil Capsules
-
Tucson, ArizonaUniversity of Arizona
Mar 11, 2021